The plasma therapy market is expected to experience growth, with some reports focusing on specific segments such as plasma derived therapy, plasma fractionation, and immunoglobulin. The market size is projected to reach significant values by 2034, with estimates including $45.29 billion for plasma derived therapy and $128.55 billion for CAR T-cell therapy. Related markets, including blood purification equipment and hyperpigmentation treatment, are also expected to grow, although specific details and projections vary across reports.